Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 9/20 | 0.36 |
| ▸ | CA2 | P00918 | 9/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | KLK1 | P06870 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19152428 | 0.81 | CA1 (0.42) | CA1CA2CA12CA9NOS3 | |
| SCHEMBL672097 | 0.78 | CA1 (0.58) | MAPTCA1CA2CA12CA9 | |
| SCHEMBL251333 | 0.77 | TSHR (0.48) | TSHRTDP1MAPTCACNA1BAPBA1 | |
| Hydrochloric Acid SCHEMBL1242368 | 0.77 | CA1 (0.56) | MAPTCA1CA2CA12CA9 | |
| SCHEMBL5568466 | 0.77 | NOS3 (0.35) | CA1CA2CA12CA9NOS3 | |
| SCHEMBL28408546 | 0.76 | NOS3 (0.33) | CA1CA2CA12CA9NOS3 | |
| SCHEMBL3812152 | 0.75 | NOS3 (0.39) | CA1CA2CA12CA9NOS3 | |
| SCHEMBL4098848 | 0.75 | CA1 (0.42) | TSHRTDP1CA1CA2CA12 | |
| Bicarbonate SCHEMBL4899567 | 0.75 | CA1 (0.55) | CA1CA2CA12CA9NOS3 | |
| SCHEMBL4586536 | 0.74 | CA1 (0.37) | TSHRTDP1CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970435-B2 | Taste-modified creatine salts, compounds, compositions and uses thereof | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2024-04-30 | — | — | US | claimed |
| US-20200148632-A1 | TASTE-MODIFIED CREATINE SALTS, COMPOUNDS, COMPOSITIONS AND USES THEREOF | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. | 2020-05-14 | — | — | US | claimed |
| WO-2018208647-A1 | TASTE-MODIFIED CREATINE SALTS, COMPOUNDS, COMPOSITIONS AND USES THEREOF | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2018-11-15 | — | — | WO | claimed |
| US-20080254198-A1 | Method of Preparing Creatine Ester Salts and Uses Thereof | BIO-ENGINEERED SUPPLEMENTS & NUTRITION, INC. (US) | 2008-10-16 | — | — | US | claimed |
| US-20080124439-A1 | Nutritional supplement composition comprising creatine and method for making the same | NATURALLY SCIENTIFIC, INC. | 2008-05-29 | — | — | US | claimed |
| US-11970435-B2 | Taste-modified creatine salts, compounds, compositions and uses thereof | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2024-04-30 | — | — | US | disclosed |
| US-20220211651-A1 | COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2022-07-07 | — | — | US | disclosed |
| EP-3941221-A1 | COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2022-01-26 | — | — | EP | disclosed |
| US-20210128467-A1 | MICRO-EMULSION CONTAINING CREATINE FATTY-ESTER, METHOD FOR PREPARING SAID MICRO-EMULSION AND USES THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2021-05-06 | — | — | US | disclosed |
| WO-2020221780-A1 | COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2020-11-05 | — | — | WO | disclosed |
| EP-3732995-A1 | COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2020-11-04 | — | — | EP | disclosed |
| US-20200148632-A1 | TASTE-MODIFIED CREATINE SALTS, COMPOUNDS, COMPOSITIONS AND USES THEREOF | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. | 2020-05-14 | — | — | US | disclosed |
| EP-3563830-A1 | MICRO-EMULSION CONTAINING CREATINE FATTY ESTER, METHOD FOR PREPARING SAID MICRO-EMULSION AND USES THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018208647-A1 | TASTE-MODIFIED CREATINE SALTS, COMPOUNDS, COMPOSITIONS AND USES THEREOF | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2018-11-15 | — | — | WO | disclosed |
| US-20080124439-A1 | Nutritional supplement composition comprising creatine and method for making the same | NATURALLY SCIENTIFIC, INC. | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128467-A1 | MICRO-EMULSION CONTAINING CREATINE FATTY-ESTER, METHOD FOR PREPARING SAID MICRO-EMULSION AND USES THEREOF | FABP7, MTTP, CETP | TSHR 2649/4885TDP1 2889/4885MAPT 1339/4885 |
| US-20220211651-A1 | COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE | FABP3, FABP7, CPT1B | TSHR 3151/4885TDP1 1709/4885MAPT 1822/4885 |
| US-20200148632-A1 | TASTE-MODIFIED CREATINE SALTS, COMPOUNDS, COMPOSITIONS AND USES THEREOF | CKMT1A; CKMT1B, TAS2R16, TAS2R4 | TSHR 2082/4885TDP1 1970/4885MAPT 3377/4885 |
| US-11970435-B2 | Taste-modified creatine salts, compounds, compositions and uses thereof | CKMT1A; CKMT1B, TAS2R16, TAS2R4 | TSHR 2082/4885TDP1 1970/4885MAPT 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.